Latent Tuberculosis Testing: What Laboratorians Need to Know
Tracking # 20-1330322
Price not reported
Course overview
Latent tuberculosis infection (LTBI) affects nearly one-quarter of the global population and represents a critical reservoir for active TB, the leading infectious cause of death globally. LTBI is asymptomatic but can progress to active TB, causing morbidity, mortality, and fueling ongoing transmission. Efficient and accurate LTBI diagnostic and management strategies are fundamental to achieving TB elimination. However, healthcare providers and laboratory professionals encounter significant challenges in LTBI testing, from identifying appropriate patients for testing and selecting optimal diagnostic methods, to accurately interpreting results and implementing effective interventions. Join Dr. Elizabeth Talbot as she presents evidence-based guidance on TB testing algorithms, including strengths and limitations of LTBI testing methods, along with strategies for identifying and prioritizing high-risk patient populations to optimize TB prevention programs.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Elizabeth Talbot, MD
- ¿Honorarium: Euroimmun
- Commitee/Advisory Board: MannKind